383 related articles for article (PubMed ID: 33579846)
1. Screening Traditional Chinese Medicine Combination for Cotreatment of Alzheimer's Disease and Type 2 Diabetes Mellitus by Network Pharmacology.
Wang YZ; Meng L; Zhuang QS; Shen L
J Alzheimers Dis; 2021; 80(2):787-797. PubMed ID: 33579846
[TBL] [Abstract][Full Text] [Related]
2. Mechanism interpretation of Guhan Yangshengjing for protection against Alzheimer's disease by network pharmacology and molecular docking.
Cheung S; Zhong Y; Wu L; Jia X; He MQ; Ai Y; Jiao Q; Liang Q
J Ethnopharmacol; 2024 Jun; 328():117976. PubMed ID: 38492794
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese Medicine studies for Alzheimer's disease via network pharmacology based on entropy and random walk.
Wu X; Cao S; Zou Y; Wu F
PLoS One; 2023; 18(11):e0294772. PubMed ID: 38019798
[TBL] [Abstract][Full Text] [Related]
4. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach.
Ren X; Shao XX; Li XX; Jia XH; Song T; Zhou WY; Wang P; Li Y; Wang XL; Cui QH; Qiu PJ; Zhao YG; Li XB; Zhang FC; Li ZY; Zhong Y; Wang ZG; Fu XJ
J Ethnopharmacol; 2020 Aug; 258():112932. PubMed ID: 32376368
[TBL] [Abstract][Full Text] [Related]
5. [Study on efficacy markers of Salviae Miltiorrhizae Radix et Rhizoma for promoting blood circulation and remving blood stasis based on systematic traditional Chinese medicine].
Ma J; Chen X; Bian YQ; Chen ZJ; Qiao YJ; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(14):3259-3265. PubMed ID: 32726038
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanism of the Effect of Huanglian Jiedu Decoction on Type 2 Diabetes Mellitus Based on Network Pharmacology and Molecular Docking.
Yin B; Bi YM; Fan GJ; Xia YQ
J Diabetes Res; 2020; 2020():5273914. PubMed ID: 33134394
[TBL] [Abstract][Full Text] [Related]
7. [Study on relevance mining of "core drug action target" in Dictionary of Traditional Chinese Medicine Prescriptions].
Wang B; Zhou RR; Tang SH
Zhongguo Zhong Yao Za Zhi; 2018 Oct; 43(19):3919-3926. PubMed ID: 30453719
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
Wang K; Yang R; Chen TT; Qin MR; Wang P; Kong MW
Chin J Integr Med; 2023 May; 29(5):413-423. PubMed ID: 36474082
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology and molecular docking approaches to elucidate the potential compounds and targets of Saeng-Ji-Hwang-Ko for treatment of type 2 diabetes mellitus.
Ko M; Kim Y; Kim HH; Jeong S; Ahn D; Chung SJ; Kim H
Comput Biol Med; 2022 Oct; 149():106041. PubMed ID: 36049411
[TBL] [Abstract][Full Text] [Related]
10. A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus.
He D; Huang JH; Zhang ZY; Du Q; Peng WJ; Yu R; Zhang SF; Zhang SH; Qin YH
Drug Des Devel Ther; 2019; 13():3989-4005. PubMed ID: 31819371
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of the Mechanisms and Molecular Targets of
Xu M; Li Z; Yang L; Zhai W; Wei N; Zhang Q; Chao B; Huang S; Cui H
Biomed Res Int; 2020; 2020():5848497. PubMed ID: 32851081
[No Abstract] [Full Text] [Related]
12. Mechanism of quercetin therapeutic targets for Alzheimer disease and type 2 diabetes mellitus.
Zu G; Sun K; Li L; Zu X; Han T; Huang H
Sci Rep; 2021 Nov; 11(1):22959. PubMed ID: 34824300
[TBL] [Abstract][Full Text] [Related]
13. Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease.
Yi P; Zhang Z; Huang S; Huang J; Peng W; Yang J
Pharm Biol; 2020 Dec; 58(1):932-943. PubMed ID: 32956608
[TBL] [Abstract][Full Text] [Related]
14. An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms.
Zhao Q; Bai J; Chen Y; Liu X; Zhao S; Ling G; Jia S; Zhai F; Xiang R
J Ethnopharmacol; 2022 Oct; 297():115567. PubMed ID: 35870684
[TBL] [Abstract][Full Text] [Related]
15. Anti-Alzheimer's Disease Molecular Mechanism of Acori Tatarinowii Rhizoma Based on Network Pharmacology.
Zhang Y; Wu Y; Fu Y; Lin L; Lin Y; Zhang Y; Ji L; Li C
Med Sci Monit Basic Res; 2020 Jun; 26():e924203. PubMed ID: 32475979
[TBL] [Abstract][Full Text] [Related]
16. Design of new traditional Chinese medicine herbal formulae for treatment of type 2 diabetes mellitus based on network pharmacology.
Hu RF; Sun XB
Chin J Nat Med; 2017 Jun; 15(6):436-441. PubMed ID: 28629533
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology and metabolomics study on the intervention of traditional Chinese medicine Huanglian Decoction in rats with type 2 diabetes mellitus.
Pan L; Li Z; Wang Y; Zhang B; Liu G; Liu J
J Ethnopharmacol; 2020 Aug; 258():112842. PubMed ID: 32333952
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of volatile oil from Alpinia oxyphylla in treating Alzheimer's disease based on GC-MS and network pharmacology].
Li WJ; Xiao S; Zheng Q; Zhu LY; Zhang MX; Yang M; Yan Y; Wang ZY
Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(12):3052-3057. PubMed ID: 34467695
[TBL] [Abstract][Full Text] [Related]
19. A network pharmacology approach to identify the mechanisms and molecular targets of curcumin against Alzheimer disease.
Wu X; Zheng X; Tang H; Zhao L; He C; Zou Y; Song X; Li L; Yin Z; Ye G
Medicine (Baltimore); 2022 Aug; 101(34):e30194. PubMed ID: 36042609
[TBL] [Abstract][Full Text] [Related]
20. Exploring the pathogenesis of depression and potential antidepressants through the integration of reverse network pharmacology, molecular docking, and molecular dynamics.
Lu Z; Gao F; Teng F; Tian X; Guan H; Li J; Wang X; Liang J; Tian Q; Wang J
Medicine (Baltimore); 2023 Nov; 102(44):e35793. PubMed ID: 37932972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
